$CATX
Perspective Therapeutics, Inc. Stock $catx

$catx Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000143774922027304 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$1.840M	$1.717M	$2.564M
YoY Change	-34.66%	-33.03%	7.55%
Cost Of Revenue	$1.430M	$1.303M	$1.535M
YoY Change	-10.4%	-15.11%	34.89%
Gross Profit	$400.0K	$414.0K	$1.029M
YoY Change	-67.21%	-59.77%	-17.42%
Gross Profit Margin	21.74%	24.11%	40.13%
Selling, General & Admin	$3.190M	$3.914M	$2.601M
YoY Change	37.5%	50.48%	57.83%
% of Gross Profit	797.5%	945.41%	252.77%
Research & Development	$590.0K	$708.0K	$702.0K
YoY Change	10.28%	0.85%	125.0%
% of Gross Profit	147.5%	171.01%	68.22%
Depreciation & Amortization	$80.00K	$68.00K	$59.00K
YoY Change	12.68%	15.25%	73.53%
% of Gross Profit	20.0%	16.43%	5.73%
Operating Expenses	$3.780M	$4.622M	$3.303M
YoY Change	32.4%	39.93%	68.52%
Operating Profit	-$3.380M	-$4.208M	-$2.274M
YoY Change	106.73%	85.05%	218.49%
Interest Expense	$420.0K	$140.0K	$31.00K
YoY Change	1254.84%	351.61%	3000.0%
% of Operating Profit
Other Income/Expense, Net		$140.0K	$31.00K
YoY Change		351.61%	3000.0%
Pretax Income	-$3.270M	-$4.068M	-$2.243M
YoY Change	103.87%	81.36%	214.59%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$3.270M	-$4.068M	-$2.243M
YoY Change	103.87%	81.36%	214.59%
Net Earnings / Revenue	-177.72%	-236.92%	-87.48%
Basic Earnings Per Share		-$0.03	-$0.02
Diluted Earnings Per Share	-$0.02	-$28.63K	-$15.81K
COMMON SHARES
Basic Shares Outstanding	142.1M	142.1M	141.9M
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$43.80M	$54.11M	$61.69M
YoY Change	-27.43%	-12.28%	3079.9%
Cash & Equivalents	$20.99M	$18.99M	$61.69M
Short-Term Investments	$22.80M	$35.12M
Other Short-Term Assets	$600.0K	$662.0K	$306.0K
YoY Change	12.15%	116.34%	-24.82%
Inventory	$1.409M	$1.553M	$1.060M
Prepaid Expenses
Receivables	$1.363M	$1.213M	$1.902M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$53.22M	$57.54M	$64.96M
YoY Change	-16.33%	-11.42%	1268.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.684M	$1.999M	$1.953M
YoY Change	-14.65%	2.36%	7.66%
Goodwill	$0.00
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments	$150.0K
YoY Change
Other Assets	$236.0K	$101.0K	$120.0K
YoY Change	114.55%	-15.83%	-6.25%
Total Long-Term Assets	$4.876M	$4.998M	$3.752M
YoY Change	33.66%	33.21%	14.43%
TOTAL ASSETS
Total Short-Term Assets	$53.22M	$57.54M	$64.96M
Total Long-Term Assets	$4.876M	$4.998M	$3.752M
Total Assets	$58.09M	$62.54M	$68.71M
YoY Change	-13.62%	-8.98%	756.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.500M	$2.495M	$768.0K
YoY Change	77.1%	224.87%	1.32%
Accrued Expenses	$1.100M	$1.506M	$1.031M
YoY Change	10.22%	46.07%	34.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.676M	$4.001M	$1.799M
YoY Change	45.04%	122.4%	18.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$800.0K	$835.0K	$1.152M
YoY Change	-21.26%	-27.52%	-18.18%
Total Long-Term Liabilities	$800.0K	$835.0K	$1.152M
YoY Change	-21.26%	-27.52%	-18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.676M	$4.001M	$1.799M
Total Long-Term Liabilities	$800.0K	$835.0K	$1.152M
Total Liabilities	$3.449M	$4.836M	$2.951M
YoY Change	20.55%	63.88%	0.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$105.9M	-$102.7M	-$93.57M
YoY Change	11.31%	9.72%	5.55%
Common Stock	$160.6M	$160.4M	$159.3M
YoY Change	0.63%	0.65%	69.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$54.64M	$57.70M	$65.76M
YoY Change
Total Liabilities & Shareholders Equity	$58.09M	$62.54M	$68.71M
YoY Change	-13.62%	-8.98%	756.2%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$3.270M	-$4.068M	-$2.243M
YoY Change	103.87%	81.36%	214.59%
Depreciation, Depletion And Amortization	$80.00K	$68.00K	$59.00K
YoY Change	12.68%	15.25%	73.53%
Cash From Operating Activities	-$4.330M	-$1.763M	-$2.084M
YoY Change	229.78%	-15.4%	516.57%
INVESTING ACTIVITIES
Capital Expenditures	$60.00K	$90.00K	$54.00K
YoY Change	-174.07%	66.67%	-52.21%
Acquisitions
YoY Change
Other Investing Activities	$6.390M	-$35.08M
YoY Change
Cash From Investing Activities	$6.330M	-$35.17M	-$54.00K
YoY Change	-7914.81%	65022.22%	-52.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$28.00K	$0.00
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-4.330M	-$1.763M	-$2.084M
Cash From Investing Activities	6.330M	-$35.17M	-$54.00K
Cash From Financing Activities	0.000	$28.00K	$0.00
Net Change In Cash	2.000M	-$36.90M	-$2.138M
YoY Change	-249.48%	1625.96%	374.06%
FREE CASH FLOW
Cash From Operating Activities	-$4.330M	-$1.763M	-$2.084M
Capital Expenditures	$60.00K	$90.00K	$54.00K
Free Cash Flow	-$4.390M	-$1.853M	-$2.138M
YoY Change	256.33%	-13.33%	374.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	142112766
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	142112766
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	142040266
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	142040266
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.56
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.56
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.62
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity File Number EntityFileNumber	001-33407
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1458152
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	350 Hills St., Suite 106
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Richland
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	99354
CY2022Q3	dei	City Area Code CityAreaCode	509
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	375-1202
CY2022Q3	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2022Q3	dei	Trading Symbol TradingSymbol	ISR
CY2022Q3	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	142112766
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18989000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	55890000	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	35123000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	1213000	usd
CY2022Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	1608000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1553000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	1396000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	662000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	435000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	57540000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	59329000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1999000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1976000	usd
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	2333000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	512000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	445000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	966000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000	usd
CY2022Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	2271000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	101000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	107000	usd
CY2022Q3	us-gaap	Assets Assets	62538000	usd
CY2022Q2	us-gaap	Assets Assets	64439000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2495000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	272000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	268000	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	201000	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	150000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	125000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	120000	usd
CY2022Q3	isr	Accrued Payroll And Related Taxes Current AccruedPayrollAndRelatedTaxesCurrent	637000	usd
CY2022Q2	isr	Accrued Payroll And Related Taxes Current AccruedPayrollAndRelatedTaxesCurrent	509000	usd
CY2022Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	271000	usd
CY2022Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	253000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4001000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2266000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	186000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	256000	usd
CY2022Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	649000	usd
CY2022Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	640000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	4836000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3162000	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	142000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	142000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	160225000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	159732000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102665000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-98597000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	57702000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	61277000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	62538000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64439000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1717000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2564000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1303000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1535000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	414000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	1029000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	708000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	702000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	800000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	761000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3114000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1840000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4622000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	3303000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4208000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2274000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	140000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	614000	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	31000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	140000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	31000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4068000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2243000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142072000
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141915000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4068000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2243000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	68000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	59000	usd
CY2022Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6000	usd
CY2021Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10000	usd
CY2022Q3	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	8000	usd
CY2021Q3	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	8000	usd
CY2022Q3	isr	Accrued Interest On Short Term Investments AccruedInterestOnShortTermInvestments	47000	usd
CY2021Q3	isr	Accrued Interest On Short Term Investments AccruedInterestOnShortTermInvestments	-0	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	465000	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	596000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-395000	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-111000	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	95000	usd
CY2021Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	796000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	227000	usd
CY2021Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-175000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1530000	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	40000	usd
CY2022Q3	isr	Increase Decrease In Accrued Protocol Expense IncreaseDecreaseInAccruedProtocolExpense	52000	usd
CY2021Q3	isr	Increase Decrease In Accrued Protocol Expense IncreaseDecreaseInAccruedProtocolExpense	22000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	5000	usd
CY2021Q3	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2000	usd
CY2022Q3	isr	Increase Decrease In Accrued Payroll And Related Taxes IncreaseDecreaseInAccruedPayrollAndRelatedTaxes	127000	usd
CY2021Q3	isr	Increase Decrease In Accrued Payroll And Related Taxes IncreaseDecreaseInAccruedPayrollAndRelatedTaxes	-62000	usd
CY2022Q3	isr	Increase Decrease In Accrued Vacation IncreaseDecreaseInAccruedVacation	18000	usd
CY2021Q3	isr	Increase Decrease In Accrued Vacation IncreaseDecreaseInAccruedVacation	-6000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1763000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2084000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	90000	usd
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54000	usd
CY2022Q3	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	35076000	usd
CY2021Q3	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	-0	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35166000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-54000	usd
CY2022Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	28000	usd
CY2021Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36901000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2138000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56072000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	64010000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19171000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61872000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	4235000
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18989000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61690000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000	usd
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	182000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19171000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61872000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	67406000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	596000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2243000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	65759000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	61277000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	28000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	465000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4068000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	57702000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13452000
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9972000
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	912000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	911000	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	2951600
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	462000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	27000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	23000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1553000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	1396000	usd
CY2022Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	2271000	usd
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	2333000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9560000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9472000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7561000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7496000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1999000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1976000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.26
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.58
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.99	pure
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	465000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	596000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1526000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M1D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10806000
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M4D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	10806000
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y2M4D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5953000
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y2M1D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	72500
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4235000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2951600
CY2022Q3	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	1092000	usd
CY2021Q3	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	1712000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	170325
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	7500
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	100000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	132500
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	79000	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	78000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	219000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	264000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	483000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	25000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	458000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	272000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	186000	usd

Files In Submission

Name	View Source	Status
0001437749-22-027304-index-headers.html	Edgar Link	pending
0001437749-22-027304-index.html	Edgar Link	pending
0001437749-22-027304.txt	Edgar Link	pending
0001437749-22-027304-xbrl.zip	Edgar Link	pending
ex_432360.htm	Edgar Link	pending
ex_432387.htm	Edgar Link	pending
ex_432388.htm	Edgar Link	pending
ex_432397.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
isr-20220930.xsd	Edgar Link	pending
isr20220930_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
isr20220930_10q_htm.xml	Edgar Link	completed
isr-20220930_cal.xml	Edgar Link	unprocessable
isr-20220930_lab.xml	Edgar Link	unprocessable
isr-20220930_def.xml	Edgar Link	unprocessable
isr-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CATX
Perspective Therapeutics, Inc. Stock $catx

2022 Q4 Form 10-Q Financial Statement

#000143774922027304 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX Perspective Therapeutics, Inc. Stock $catx

2022 Q4 Form 10-Q Financial Statement

#000143774922027304 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX
Perspective Therapeutics, Inc. Stock $catx